DCL Corporation Commences U.S. and Canadian Restructuring Cases to Facilitate Sale of Business

To facilitate the ongoing process to sell its businesses,  DCL Corporation (DCL or the Company), a leading manufacturer and reseller of color pigments, announced today that, on December 20, 2022, its United States based subsidiaries have filed voluntary petitions for a court-supervised reorganization under Chapter 11 of the Bankruptcy Code (Chapter 11) in the U.S. […]

thaipr.net

22 ธ.ค. 65

Fitch Affirms Asia Plus Group Holdings at ‘A(tha)’; Outlook Stable

Fitch Ratings (Thailand) has affirmed Asia Plus Group Holdings Public Company Limited’s (ASP) National Long-Term Rating at ‘A(tha)’ with a Stable Outlook. Fitch has also affirmed ASP’s National Short-Term Rating at ‘F1(tha)’. KEY RATING DRIVERSRatings Reflect Standalone Strength: ASP’s National Long-Term Rating reflects its established and diversified securities franchise, which supports its superior…

thaipr.net

19 ธ.ค. 65

Fitch Affirms Finansia Syrus’ National Long-Term Rating at ‘BBB+(tha)’; Outlook Stable

Fitch Ratings (Thailand) has affirmed Finansia Syrus Securities Public Company Limited’s (FSS) National Long-Term Rating at ‘BBB+(tha)’ The Outlook is Stable. Fitch has also affirmed the National Short-Term Rating at ‘F2(tha)’. KEY RATING DRIVERSStandalone Profile Underpins Ratings: The ratings of FSS reflect an established retail franchise in Thailand’s competitive securities brokerage industry, as well as…

thaipr.net

19 ธ.ค. 65

Fitch Assigns DAOL SECURITIES (THAILAND)’s THB Subordinated Debentures ‘BB(tha)’ Rating; on RWN

Fitch Ratings (Thailand) has assigned a National Long-Term Rating of ‘BB(tha)’ to DAOL SECURITIES (THAILAND) PUBLIC COMPANY LIMITED’s (DAOLSEC, BB+(tha)/Rating Watch Negative (RWN)/B(tha)) upcoming issue of up to THB300 million in subordinated unsecured debentures. The RWN on the subordinated debentures is consistent with the RWN of DAOLSEC’s National Long-Term Rating. The debentures have a maturity […]

thaipr.net

15 ธ.ค. 65

Novavax Announces Proposed $125 Million Public Offering of Common Stock

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced a proposed underwritten public offering to sell up to $125 million of its common stock. In connection with the common stock offering, Novavax expects to grant to the underwriters a 30-day option to purchase up to an additional $18.75 million of its common stock at the public…

thaipr.net

15 ธ.ค. 65

Another very successful year for the ZEISS Group

Significant revenue growth of 8.8 billion euros despite challenging geopolitical and economic conditions – EBIT at 1.6 billion euros (up 109 million euros compared to the prior year). The ZEISS Group once again significantly surpassed the strong prior-year level. All four ZEISS segments have shown double-digit percentage growth Focused investment strategy with high expenditure on […]

thaipr.net

14 ธ.ค. 65
1 32 33 34 35 36 105